Pharma Company - 6738

"Full-service shop, from R&D to commercialization"

Listing Price: >$15M Revenue: $7.5-10M Cash Flow: $1-2.5M

The company provides pharmaceutical products to a USDA-approved audience, but is looking to expand into Canada, UK, Europe and Australia. The Company’s current R&D and manufacturing is fully sold through the marketing partners, who have co-invested in the drug development, underwriting full marketing of products. The firm provides end-to-end prescription generics drug development, manufacturing and commercialization. This is a high growth potential business, located in the US that primarily generates revenue through project or job based contracts with a strong reputation for product differentiation.